C-reactive protein (CRP) is an acute phase inflammatory protein that has well-validated utility in predicting acute cardiac events (e.g., myocardial infarction, stroke, sudden cardiac death) in non-irradiated populations but is less explored in patients receiving cancer therapies in general and radiation therapy for thoracic cancers in particular [53]. This evidence concerns the gene CRP and stroke disorder.